1
|
Marziali M, Pugliese P, Losardo AA, Ribersani M, Anastasi E, Angeloni A, Pavan A, Gentile G. Efficacy and safety of BNT162b2 mRNA vaccine in a cohort of 90 transfusion dependent thalassemia patients. Transfus Med 2024. [PMID: 38632665 DOI: 10.1111/tme.13038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2023] [Revised: 01/29/2024] [Accepted: 03/20/2024] [Indexed: 04/19/2024]
Affiliation(s)
- M Marziali
- Immunohematology and Transfusion Medicine Unit, Policlinico Umberto I, Sapienza Università di Roma, Rome, Italy
| | - P Pugliese
- Immunohematology and Transfusion Medicine Unit, Policlinico Umberto I, Sapienza Università di Roma, Rome, Italy
| | - A A Losardo
- Immunohematology and Transfusion Medicine Unit, Policlinico Umberto I, Sapienza Università di Roma, Rome, Italy
| | - M Ribersani
- Hematology, Policlinico Umberto I, Sapienza Università di Roma, Rome, Italy
| | - E Anastasi
- Department of Experimental Medicine, Policlinico Umberto I, Sapienza Università di Roma, Rome, Italy
| | - A Angeloni
- Department of Experimental Medicine, Policlinico Umberto I, Sapienza Università di Roma, Rome, Italy
| | - A Pavan
- Immunohematology and Transfusion Medicine Unit, Policlinico Umberto I, Sapienza Università di Roma, Rome, Italy
| | - G Gentile
- Department of Translational and Precision Medicine, Sapienza Università di Roma, Rome, Italy
| |
Collapse
|
2
|
Pavan A, Cendron L, Di Nisio A, Pedrucci F, Sabovic I, Scarso A, Ferlin A, Angelini A, Foresta C, De Toni L. In vitro binding analysis of legacy-linear and new generation-cyclic perfluoro-alkyl substances on sex hormone binding globulin and albumin, suggests low impact on serum hormone kinetics of testosterone. Toxicology 2023; 500:153664. [PMID: 37931871 DOI: 10.1016/j.tox.2023.153664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2023] [Revised: 10/27/2023] [Accepted: 10/30/2023] [Indexed: 11/08/2023]
Abstract
In humans, serum testosterone (T) is largely bound to the sex hormone binding globulin (SHBG) and human serum albumin (hSA), resulting in a 2-3 % of unbound or "free" active quote (FT). Endocrine-disrupting chemicals, including perfluoro-alkyl substances (PFAS), are recognized to interfere with the hormonal axes, but the possible impact on the FT quote has not been addressed so far. Here we investigated the possible competition of two acknowledged PFAS molecules on T binding to SHBG and hSA. In particular, perfluoro-octanoic acid (PFOA) and acetic acid, 2,2-difluoro-2-((2,2,4,5-tetrafluoro-5(trifluoromethoxy)-1,3-dioxolan-4-yl)oxy)-ammonium salt (1:1) (C6O4) were used as, respectively, legacy-linear and new-generation-cyclic PFASs. Human recombinant SHBG 30-234 domain (SHBG30-234), produced in HEK293-F cells, and delipidated recombinant hSA were used as in vitro protein models. Isothermal Titration Calorimetry (ITC) and tryptophan fluorescence quencing (TFQ) were used to evaluate the binding modes of T and PFAS to SHBG30-234 and hSA. ITC revealed the binding of T to SHBG30-234 with a Kd of 44 ± 2 nM whilst both PFOA and C6O4 showed no binding activity. Results were confirmed by TFQ, since only T modified the fluorescence profile of SHBG30-234. In hSA, TFQ confirmed the binding of T on FA6 site of the protein. A similar binding mode was observed for PFOA but not for C6O4, as further verified by displacement experiments with T. Although both PFASs were previously shown to bind hSA, only PFOA is predicted to possibly compete with T for the binding to hSA. However, on the base of the binding stoichiometry and affinity of PFOA for hSA, this appears unlikely at the blood concentrations of the chemical documented to date.
Collapse
Affiliation(s)
- Angela Pavan
- Department of Biology, University of Padova, Padova, Italy
| | - Laura Cendron
- Department of Biology, University of Padova, Padova, Italy
| | - Andrea Di Nisio
- Deparment of Medicine, Unit of Andrology and Reproductive Medicine, University of Padova, Padova, Italy
| | - Federica Pedrucci
- Deparment of Medicine, Unit of Andrology and Reproductive Medicine, University of Padova, Padova, Italy
| | - Iva Sabovic
- Deparment of Medicine, Unit of Andrology and Reproductive Medicine, University of Padova, Padova, Italy
| | - Alessandro Scarso
- Department of Molecular Sciences and Nanosystems, Università Ca' Foscari Venezia, Venezia, Italy
| | - Alberto Ferlin
- Deparment of Medicine, Unit of Andrology and Reproductive Medicine, University of Padova, Padova, Italy
| | - Alessandro Angelini
- Department of Molecular Sciences and Nanosystems, Università Ca' Foscari Venezia, Venezia, Italy; European Centre for Living Technology (ECLT), Ca' Bottacin, Venice, Italy
| | - Carlo Foresta
- Deparment of Medicine, Unit of Andrology and Reproductive Medicine, University of Padova, Padova, Italy.
| | - Luca De Toni
- Deparment of Medicine, Unit of Andrology and Reproductive Medicine, University of Padova, Padova, Italy
| |
Collapse
|
3
|
Pasello G, Lorenzi M, Tosi A, Roma A, Pavan A, Scapinello A, Lonardi S, Ferro A, Maso AD, Frega S, Bonanno L, Del Bianco P, Guarneri V, Rosato A. 164P Immune cells distribution and spatial relationship within microenvironment as predictive biomarkers of benefit in extended stage small cell lung cancer patients receiving atezolizumab plus carboplatin and etoposide as first-line treatment. J Thorac Oncol 2023. [DOI: 10.1016/s1556-0864(23)00418-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/04/2023]
|
4
|
Cassari L, Pavan A, Zoia G, Chinellato M, Zeni E, Grinzato A, Rothenberger S, Cendron L, Dettin M, Pasquato A. SARS-CoV-2 S Mutations: A Lesson from the Viral World to Understand How Human Furin Works. Int J Mol Sci 2023; 24:4791. [PMID: 36902222 PMCID: PMC10003014 DOI: 10.3390/ijms24054791] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2023] [Revised: 02/17/2023] [Accepted: 02/20/2023] [Indexed: 03/06/2023] Open
Abstract
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the etiological agent responsible for the worldwide pandemic and has now claimed millions of lives. The virus combines several unusual characteristics and an extraordinary ability to spread among humans. In particular, the dependence of the maturation of the envelope glycoprotein S from Furin enables the invasion and replication of the virus virtually within the entire body, since this cellular protease is ubiquitously expressed. Here, we analyzed the naturally occurring variation of the amino acids sequence around the cleavage site of S. We found that the virus grossly mutates preferentially at P positions, resulting in single residue replacements that associate with gain-of-function phenotypes in specific conditions. Interestingly, some combinations of amino acids are absent, despite the evidence supporting some cleavability of the respective synthetic surrogates. In any case, the polybasic signature is maintained and, as a consequence, Furin dependence is preserved. Thus, no escape variants to Furin are observed in the population. Overall, the SARS-CoV-2 system per se represents an outstanding example of the evolution of substrate-enzyme interaction, demonstrating a fast-tracked optimization of a protein stretch towards the Furin catalytic pocket. Ultimately, these data disclose important information for the development of drugs targeting Furin and Furin-dependent pathogens.
Collapse
Affiliation(s)
- Leonardo Cassari
- Department of Industrial Engineering, University of Padova, Via Marzolo 9, 35131 Padova, Italy
| | - Angela Pavan
- Department of Biology, University of Padua, Viale G. Colombo 3, 35131 Padova, Italy
| | - Giulia Zoia
- Department of Biology, University of Padua, Viale G. Colombo 3, 35131 Padova, Italy
| | - Monica Chinellato
- Department of Biology, University of Padua, Viale G. Colombo 3, 35131 Padova, Italy
| | - Elena Zeni
- Department of Industrial Engineering, University of Padova, Via Marzolo 9, 35131 Padova, Italy
| | - Alessandro Grinzato
- European Synchrotron Radiation Facility, 71, Avenue des Martyrs, 38000 Grenoble, France
| | - Sylvia Rothenberger
- Institute of Microbiology, University Hospital Center and University of Lausanne, Rue du Bugnon 48, 1011 Lausanne, Switzerland
- Spiez Laboratory, Federal Office for Civil Protection, Austrasse, 3700 Spiez, Switzerland
| | - Laura Cendron
- Department of Biology, University of Padua, Viale G. Colombo 3, 35131 Padova, Italy
| | - Monica Dettin
- Department of Industrial Engineering, University of Padova, Via Marzolo 9, 35131 Padova, Italy
| | - Antonella Pasquato
- Department of Industrial Engineering, University of Padova, Via Marzolo 9, 35131 Padova, Italy
| |
Collapse
|
5
|
Lorenzi M, Scattolin D, Del Conte A, Sangiorgi S, Polo V, Pavan A, Pilotto S, Santarpia M, Da Ros V, Maso AD, Ferro A, Frega S, Bortolami A, Bonanno L, Indraccolo S, Guarneri V, Pasello G. EP08.02-104 Osimertinib in Untreated EGFR-Mutant Non-small Cell Lung Cancers: Overall Survival and Budget Impact Analysis in Real-World. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.787] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
6
|
Pretelli G, Pavan A, Dal Maso A, Resi M, Mulargiu C, Ferro A, Benetti B, Lorenzi M, Marinato G, Frega S, Pasello G, Conte P, Guarneri V, Bonanno L. 63P Immune-related adverse events (irAEs) in advanced non-small cell lung cancer (aNSCLC) patients (pts): Neutrophil to lymphocyte ratio (NLR) and the risk for toxicity recurrence. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.02.072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
7
|
Pretelli G, Pavan A, Dal Maso A, Resi M, Mulargiu C, Ferro A, Benetti B, Lorenzi M, Marinato G, Frega S, Pasello G, Conte P, Guarneri V, Bonanno L. 40P Immune-related adverse events (irAEs) in advanced non-small cell lung cancer (aNSCLC) patients (pts): A real-world analysis. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.02.049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
8
|
Bonanno L, Zulato E, Del Bianco P, Nardo G, Attili I, Pavan A, Bragadin AB, Marra L, Calabrese F, Fassan M, Pasello G, Guarneri V, Conte P, Indraccolo S. MA07.01 Dynamic Liquid Biopsy During Immunotherapy Anticipates Hyperprogression And Early Death in Advanced Non-Small Cell Lung Cancer. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.08.140] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
9
|
Fu X, Padmanabhan M, Kumar RG, Basu S, Dorius S, Pavan A. Measuring the impact of influence on individuals: roadmap to quantifying attitude. Soc Netw Anal Min 2021. [DOI: 10.1007/s13278-021-00763-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
10
|
Bonanno L, Dal Maso A, Pavan A, Zulato E, Esposito G, Fassan M, Nardo G, Pasello G, Guarneri V, Calabrese F, Rea F, Indraccolo S, Conte P. 51P Liver kinase B1 (LKB1) and phosphorylated AMP kinase (AMPK) expression in small cell lung cancer (SCLC): Association with prognosis and tumour immune microenvironment (TIME) features. J Thorac Oncol 2021. [DOI: 10.1016/s1556-0864(21)01893-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
11
|
Bonanno L, Zulato E, Attili I, Nardo G, Pavan A, Paola D, Boscolo Bragadin A, Pasello G, Guarneri V, Conte P, Indraccolo S. 1939P Potential role of longitudinal plasma next generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) experiencing hyperprogression (HPD) and early death (ED) during treatment with immune checkpoint inhibitors (ICIs). Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
12
|
Bonanno L, Pavan A, Ferro A, Calvetti L, Frega S, Pasello G, Aprile G, Guarneri V, Conte P. Clinical impact of plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz257.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
13
|
Pavan A, Calvetti L, Dal Maso A, Fabozzi A, Piccin L, Chiarion-Sileni V, Pasello G, Aprile G, Guarneri V, Conte P, Bonanno L. Circulating biomarkers and risk of immune-related adverse events (irAEs) in patients (pts) with advanced non-small cell lung cancer (aNSCLC) and metastatic melanoma (mMel). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz239.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
14
|
Pavan A, Attili I, Pasello G, Guarneri V, Conte PF, Bonanno L. Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges. J Immunother Cancer 2019; 7:205. [PMID: 31383005 PMCID: PMC6683488 DOI: 10.1186/s40425-019-0690-1] [Citation(s) in RCA: 59] [Impact Index Per Article: 11.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2019] [Accepted: 07/24/2019] [Indexed: 12/17/2022] Open
Abstract
Management of small cell lung cancer (SCLC) has not changed over the last decades. In more recent years, alterations of DNA repair machinery and other molecular pathways have been identified in SCLC and preclinical data suggest that dysregulation of these pathways might offer new therapeutic opportunities. While immune checkpoint inhibitors (ICIs) have had a major impact on the clinical outcome of several solid tumors, including non-small cell lung cancer, the potential role of ICIs is currently under investigation in SCLC and some promising data are available. However, several clinical and biological hurdles have to be overcome and predictive markers are still eagerly needed. Knowledge of molecular pathways specifically involved in SCLC growth and treatment resistance is essential for a more rational planning of new combinations including ICIs. The present manuscript summarizes the current clinical evidence on immunotherapy in SCLC, describes the molecular bases underlying treatment resistance and discusses the potentialities and the rationale of different therapeutic combinations.
Collapse
Affiliation(s)
- A Pavan
- Medical Oncology 2, Istituto Oncologico Veneto IOV IRCCS, Via Gattamelata 64, 35100, Padova, Italia.,Department of Surgery, Oncology and Gastroenterology, Università degli Studi di Padova, Padova, Italia
| | - I Attili
- Medical Oncology 2, Istituto Oncologico Veneto IOV IRCCS, Via Gattamelata 64, 35100, Padova, Italia.,Department of Surgery, Oncology and Gastroenterology, Università degli Studi di Padova, Padova, Italia
| | - G Pasello
- Medical Oncology 2, Istituto Oncologico Veneto IOV IRCCS, Via Gattamelata 64, 35100, Padova, Italia
| | - V Guarneri
- Medical Oncology 2, Istituto Oncologico Veneto IOV IRCCS, Via Gattamelata 64, 35100, Padova, Italia.,Department of Surgery, Oncology and Gastroenterology, Università degli Studi di Padova, Padova, Italia
| | - P F Conte
- Medical Oncology 2, Istituto Oncologico Veneto IOV IRCCS, Via Gattamelata 64, 35100, Padova, Italia.,Department of Surgery, Oncology and Gastroenterology, Università degli Studi di Padova, Padova, Italia
| | - L Bonanno
- Medical Oncology 2, Istituto Oncologico Veneto IOV IRCCS, Via Gattamelata 64, 35100, Padova, Italia.
| |
Collapse
|
15
|
Cox C, Castiello L, Mattei M, Santodonato L, D'agostino G, Muraro E, Martorelli D, Lapenta C, Di Napoli A, Di Landro F, Cangemi M, Pavan A, Castaldo P, Hohaus S, Donati S, Montefiore E, Berdini C, Borgioni S, Carlei D, Monque D, Ruco L, Prosperi D, Tafuri A, Spadaro F, Sestili P, Spada M, Dolcetti R, Santini S, Rozera C, Arico' E, Capone I, Belardelli F. INTRANODAL TREATMENT WITH IFNΑ-DENDRITIC CELLS AND RITUXIMAB INDUCES SYSTEMIC CLINICAL RESPONSE AND ENDOGENOUS VACCINATION AGAINST FOLLICULAR LYMPHOMA: FINAL RESULT OF A PHASE I STUDY. Hematol Oncol 2019. [DOI: 10.1002/hon.126_2630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- C. Cox
- Haematology; AOU Sant'Andrea, Rome, Italy & King's College Foundation Trust; London United Kingdom
| | - L. Castiello
- FaBioCell; Core Facilities, Istituto Superiore di Sanita'; Rome Italy
| | - M. Mattei
- Radiology; AOU Sant'Andrea; Rome Italy
| | - L. Santodonato
- FaBioCell; Core Facilities, Istituto Superiore di Sanita'; Rome Italy
| | - G. D'agostino
- FaBioCell; Core Facilities, Istituto Superiore di Sanita'; Rome Italy
| | - E. Muraro
- Oncology; Centro di Riferimento Oncologico di Aviano (CRO), IRCCS; Aviano Italy
| | - D. Martorelli
- Oncology; Centro di Riferimento Oncologico di Aviano (CRO), IRCCS; Aviano Italy
| | - C. Lapenta
- Department of Oncology and Molecular Medicine; Istituto Superiore di Sanita'; Rome Italy
| | - A. Di Napoli
- Department of Clinical and Molecular Medicine; AOU Sant'Andrea; Rome Italy
| | - F. Di Landro
- Institute of Hematology; Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli, IRCCS; Rome Italy
| | - M. Cangemi
- Oncology; Centro di Riferimento Oncologico di Aviano (CRO), IRCCS; Aviano Italy
| | - A. Pavan
- Department of Clinical and Molecular Medicine; AOU Sant'Andrea; Rome Italy
| | | | - S. Hohaus
- Institute of Hematology; Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli, IRCCS; Rome Italy
| | - S. Donati
- Department of Oncology and Molecular Medicine; Istituto Superiore di Sanita'; Rome Italy
| | - E. Montefiore
- FaBioCell; Core Facilities, Istituto Superiore di Sanita'; Rome Italy
| | | | | | - D. Carlei
- FaBioCell; Core Facilities, Istituto Superiore di Sanita'; Rome Italy
| | - D. Monque
- FaBioCell; Core Facilities, Istituto Superiore di Sanita'; Rome Italy
| | - L. Ruco
- Department of Clinical and Molecular Medicine; AOU Sant'Andrea; Rome Italy
| | - D. Prosperi
- Nuclear Medicine; AOU Sant'Andrea; Rome Italy
| | - A. Tafuri
- Department of Clinical and Molecular Medicine; AOU Sant'Andrea; Rome Italy
| | - F. Spadaro
- Department of Oncology and Molecular Medicine; Istituto Superiore di Sanita'; Rome Italy
| | - P. Sestili
- Department of Oncology and Molecular Medicine; Istituto Superiore di Sanita'; Rome Italy
| | - M. Spada
- FaBioCell; Core Facilities, Istituto Superiore di Sanita'; Rome Italy
| | - R. Dolcetti
- Diamantina Institute; Translational Research Institute, The University of Queensland; Brisbane Australia
| | - S. Santini
- Department of Oncology and Molecular Medicine; Istituto Superiore di Sanita'; Rome Italy
| | - C. Rozera
- FaBioCell; Core Facilities, Istituto Superiore di Sanita'; Rome Italy
| | - E. Arico'
- FaBioCell; Core Facilities, Istituto Superiore di Sanita'; Rome Italy
| | - I. Capone
- FaBioCell; Core Facilities, Istituto Superiore di Sanita'; Rome Italy
| | - F. Belardelli
- institute of Translational Pharmacology; CNR; Rome Italy
| |
Collapse
|
16
|
Bonanno L, Zulato E, Attili I, Pavan A, Del Bianco P, Nardo G, Boscolo Bragadin A, Pasqualini L, Calabrese F, Fassan M, Pasello G, Guarneri V, Amadori A, Conte P, Indraccolo S. Potentialities of liquid biopsy in advanced non-small cell lung cancer (aNSCLC): Early evaluation of sentinel mutations in plasma and outcome of patients treated with immunotherapy. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz073.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
17
|
Pavan A, Calvetti L, Dal Maso A, Attili I, Pasello G, Aprile G, Guarneri V, Conte P, Bonanno L. Immune-related adverse events (irAEs) in advanced non-small cell lung cancer (aNSCLC): Platelet-to-lymphocyte ratio (PLR) predicts the risk of development and relapse. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz063.056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
18
|
Visco V, Vulpiani M, Torrisi M, Ferretti A, Pavan A, Vetrano M. Experimental studies on the biological effects of extracorporeal shock wave therapy on tendon models. A review of the literature. Muscles Ligaments Tendons J 2019. [DOI: 10.32098/mltj.03.2014.15] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- V. Visco
- Department of Clinical and Molecular Medicine, “Sapienza” University of Rome, Italy; Sant’Andrea Hospital, Rome, Italy
| | - M.C. Vulpiani
- Department of Ortophaedics and Traumatology, “Sapienza” University of Rome, Italy; Sant’Andrea Hospital, Rome, Italy
| | - M.R. Torrisi
- Department of Clinical and Molecular Medicine, “Sapienza” University of Rome, Italy; Sant’Andrea Hospital, Rome, Italy
| | - A. Ferretti
- Department of Ortophaedics and Traumatology, “Sapienza” University of Rome, Italy; Sant’Andrea Hospital, Rome, Italy
| | - A. Pavan
- Department of Clinical and Molecular Medicine, “Sapienza” University of Rome, Italy; Sant’Andrea Hospital, Rome, Italy
| | - M. Vetrano
- Department of Ortophaedics and Traumatology, “Sapienza” University of Rome, Italy; Sant’Andrea Hospital, Rome, Italy
| |
Collapse
|
19
|
Erroi D, Sigona M, Suarez T, Trischitta D, Pavan A, Vulpiani M, Vetrano M. Conservative treatment for Insertional Achilles Tendinopathy: platelet-rich plasma and focused shock waves. A retrospective study. Muscles Ligaments Tendons J 2019. [DOI: 10.32098/mltj.01.2017.13] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- D. Erroi
- Physical Medicine and Rehabilitation Unit, Sant’Andrea Hospital, “Sapienza” University of Rome, Italy
| | - M. Sigona
- Physical Medicine and Rehabilitation Unit, Sant’Andrea Hospital, “Sapienza” University of Rome, Italy
| | - T. Suarez
- Physical Medicine and Rehabilitation Unit, Sant’Andrea Hospital, “Sapienza” University of Rome, Italy
| | - D. Trischitta
- Physical Medicine and Rehabilitation Unit, Sant’Andrea Hospital, “Sapienza” University of Rome, Italy
| | - A. Pavan
- Department of Immunohematology and Transfusion, Sant’Andrea Hospital, “Sapienza” University of Rome, Italy
| | - M.C. Vulpiani
- Physical Medicine and Rehabilitation Unit, Sant’Andrea Hospital, “Sapienza” University of Rome, Italy
| | - M. Vetrano
- Physical Medicine and Rehabilitation Unit, Sant’Andrea Hospital, “Sapienza” University of Rome, Italy
| |
Collapse
|
20
|
Bonanno L, Zulato E, Attili I, Pavan A, Del Bianco P, Nardo G, Verza M, Pasqualini L, Pasello G, Zago G, Frega S, Fassan M, Calabrese F, Amadori A, Guarneri V, Conte P, Indraccolo S. Liquid biopsy as tool to monitor and predict clinical benefit from chemotherapy (CT) and immunotherapy (IT) in advanced non-small cell lung cancer (aNSCLC): A prospective study. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy303] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
21
|
Bonanno L, Pavan A, Dieci MV, Di Liso E, Schiavon M, Comacchio G, Attili I, Pasello G, Calabrese F, Rea F, Favaretto A, Rugge M, Guarneri V, Fassan M, Conte PF. The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes. Eur J Cancer 2018; 101:191-200. [PMID: 30077124 DOI: 10.1016/j.ejca.2018.06.023] [Citation(s) in RCA: 72] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2018] [Revised: 06/18/2018] [Accepted: 06/20/2018] [Indexed: 10/28/2022]
Abstract
INTRODUCTION The prognosis of small-cell lung cancer (SCLC) is dismal and new effective therapies are needed. Immunotherapy looks promising, but no molecular predictive markers are currently available, and data on immune microenvironment are very limited. METHODS We retrospectively analysed 104 SCLC cases. Immunohistochemistry evaluation of PD-L1 was performed both on tumour cells (TCs) and on tumour-infiltrating immune cells (TIICs) by using anti-PD-L1 22C3 antibody (DAKO) and categorised by using 1% as cut-off point. Tumour-infiltrating lymphocytes (TILs) were characterised by using anti-CD8 and anti-FOXP3 antibodies. Semi-quantitative score was used and categorised as positive versus negative/low. The relation of molecular markers with prognosis and with clinical variables was evaluated. RESULTS The analysis included 66 stage I-III patients (48 surgically resected, 18 treated with radical-intent chemoradiotherapy) and 38 metastatic cases. In the overall study population, PD-L1 was expressed on TCs and TIICs in 25% and 40% of cases, respectively. The proportion of PD-L1-positive cases was significantly higher in stage I-III versus metastatic patients (32% versus 13%, p: 0.034 for TCs; 51.5% versus 21% for TIICs, p: 0.002). CD8- and FOXP3-positive TILs were present in 59% and 72% of samples, respectively. The presence of FOXP3-TILs was associated with improved prognosis among non-metastatic patients, with a hazard ratio for survival of 0.32 (95% confidence interval [CI]: 0.16-0.7, p: 0.006) for univariate analysis, and 0.37 (95% CI: 0.17-0.81, p: 0.013) for multivariate analysis. CONCLUSIONS Immune contexture of SCLC may differ according to stage. The presence of FOXP3-positive TILs is a potential prognostic marker for stage I-III SCLCs and warrants further investigation.
Collapse
Affiliation(s)
- L Bonanno
- Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy.
| | - A Pavan
- Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology, Università Degli Studi di Padova, Padova, Italy
| | - M V Dieci
- Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology, Università Degli Studi di Padova, Padova, Italy
| | - E Di Liso
- Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy
| | - M Schiavon
- Thoracic Surgery, Department of Cardiothoracic and Vascular Sciences, Università Degli Studi di Padova, Padova, Italy
| | - G Comacchio
- Thoracic Surgery, Department of Cardiothoracic and Vascular Sciences, Università Degli Studi di Padova, Padova, Italy
| | - I Attili
- Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology, Università Degli Studi di Padova, Padova, Italy
| | - G Pasello
- Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy
| | - F Calabrese
- Pathology, Department of Cardiothoracic and Vascular Sciences, Università Degli Studi di Padova, Padova, Italy
| | - F Rea
- Thoracic Surgery, Department of Cardiothoracic and Vascular Sciences, Università Degli Studi di Padova, Padova, Italy
| | | | - M Rugge
- Department of Medicine (DIMED), Surgical Pathology Unit, Università Degli Studi di Padova, Padova, Italy
| | - V Guarneri
- Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology, Università Degli Studi di Padova, Padova, Italy
| | - M Fassan
- Department of Medicine (DIMED), Surgical Pathology Unit, Università Degli Studi di Padova, Padova, Italy
| | - P F Conte
- Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology, Università Degli Studi di Padova, Padova, Italy
| |
Collapse
|
22
|
Pasello G, Zago G, Lunardi F, Urso L, Kern I, Vlacic G, Grosso F, Mencoboni M, Ceresoli G, Schiavon M, Pezzuto F, Pavan A, Vuljan S, Del Bianco P, Conte P, Rea F, Calabrese F. Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical–pathological features and intratumor heterogeneity over time. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy086] [Citation(s) in RCA: 57] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
|
23
|
Pavan A, Fassan M, Dieci M, Attili I, Pasello G, Calabrese F, Rea F, Rugge M, Conte P, Bonanno L. 78O Immune microenvironment of small cell lung cancer (SCLC): Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumor infiltrating lymphocytes. J Thorac Oncol 2018. [DOI: 10.1016/s1556-0864(18)30353-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
24
|
Bonanno L, Attili I, Zulato E, Nardo G, Verza M, Pavan A, Del Bianco P, Pasello G, Zago G, Polo V, Frega S, Milite N, Carlucci M, Calabrese F, De Salvo G, Conte P, Indraccolo S. P3.02-006 Monitoring Genetic Alterations in Plasma during Anti-Cancer Treatment in Advanced NSCLC (MAGIC1-Validation Cohort: Preliminary Results). J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1535] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
25
|
Di Liso E, Pavan A, Schiavon M, Gregori D, Comacchio G, Attili I, Mantiero M, Pasello G, Zago G, Polo V, Frega S, Milite N, Rea F, Conte P, Bonanno L. Surgery in multimodal management in non-metastatic small cell lung cancer: a retrospective monocentric series. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx426.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
26
|
Frega S, Macerelli M, Del Conte A, Bonanno L, Bartoletti M, Polo V, Zago G, Follador A, Attili I, Pavan A, Urso L, Basso S, Fasola G, Conte P, Pasello G. Clinical features of never smoker patients with lung squamous cell carcinoma: a retrospective multicenter study. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx426.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
27
|
Zago G, Lunardi F, Calabrese F, Vuljan S, Urso L, Frega S, Pavan A, Polo V, Bonanno L, Attili I, Rea F, Conte P, Pasello G. Malignant pleural mesothelioma immune microenvironment and checkpoint expression before and after systemic cytotoxic treatment. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx389.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
28
|
Frega S, Macerelli M, Del Conte A, Bonanno L, Bartoletti M, Polo V, Zago G, Follador A, Attili I, Pavan A, Urso L, Basso S, Fasola G, Conte P, Pasello G. Clinical features of never smoker patients with lung squamous cell carcinoma: A retrospective multicenter study. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx380.074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
29
|
Bodina A, Pavan A, Castaldi S. Resource allocation criteria in a hospital. J Prev Med Hyg 2017; 58:E184-E189. [PMID: 28900360 PMCID: PMC5584089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
INTRODUCTION Allocate fixed resources among competing users is a challenge in terms of hospital management in order to obtain the best performance considering strategic objectives. In order to address this need, a system of evaluation in an important research and teaching hospital was designed. This study describes resource allocation criteria in a hospital focusing on the evaluation system and its developed application methodology. METHODS The indicator system allows the strategic management to rapidly detect the priorities in the evaluations of the Strategic, Organizational, Managerial, Economic, Research and Qualitative conditions of each unit. The chosen indicators are expressed with three numerical values, (1 indicating critical status, 2 acceptable conditions and 3 a good operational situation). RESULTS AND DISCUSSION The adopted evaluation system considered different thematic areas: Strategic, Organizational, Managerial, Economic, Research and Qualitative. In order to define each area, 3 fields of evaluation have been chosen. The indicators have been structured according to a pyramid system allowing creating a single indicator for each area for each unit. Furthermore, a single indicator has been fixed in order to facilitate a first consideration on whether to carry out or not closer examinations of the most critical units. This manuscript describes an attempt to define objective criteria for the allocation of scarce resources in order to achieve the hospital's strategic objectives. The indicators identified allow to obtain an overall score for each unit, which allows the management to prioritize the needs.
Collapse
Affiliation(s)
- A. Bodina
- Postgraduate School in Public Health, University of Milan, Italy
| | - A. Pavan
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - S. Castaldi
- Postgraduate School in Public Health, University of Milan, Italy;, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy,Correspondence: Silvana Castaldi, Dipartimento di Scienze Biomediche per la Salute, via Pascal 36, 20133 Milano - Tel. +39 02 55038342 - Fax +39 02 55033144 - E-mail:
| |
Collapse
|
30
|
Attili I, Frega S, Pavan A, Pasello G, Polo V, Zago G, Rea F, Calabrese F, Conte P, Bonanno L. Thymoma and thymic carcinoma: A real-life retrospective analysis. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx093.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
31
|
Pavan A, Gall M, Greenlee MW. Motion-priming in crowding: evidence for motion averaging. J Vis 2014. [DOI: 10.1167/14.10.777] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
32
|
Macchi L, Pavan A. [Reorganize hospitals to improve efficiency and quality]. Ann Ig 2014; 26:11-14. [PMID: 25486686] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
The current economic difficulties and the changed epidemiological picture, characterized by an increase in life expectancy, which shows in the elderly, chronically ill and disabled the main, both health and social, care needs,r equires a remark on the hospital network and organization. Today, most of the application assistance is usually at low intensity of care, whereas the acute event is shrinking. The prevalence of hospital admissions concern the elderly, who get into acute events but on a substrate of chronicity and co-morbidity conditions. There must be a new model of hospital network, with the possibility of converting some hospital centres for medium intensity care and selecting few centres for high intensity care, where concentrating the more expensive technology and the skill and expertise of the professional. The -suggestion is a renewed health planning that detects:- hospitals for widespread disease, equipped with emergency war for minor codes-hospital at high intensity of care for emergency-urgency- hospital for particular fields of medical speciality and research.
Collapse
|
33
|
Scavia G, Ciaravino G, Luzzi I, Lenglet A, Ricci A, Barco L, Pavan A, Zaffanella F, Dionisi AM. A multistate epidemic outbreak of Salmonella Goldcoast infection in humans, June 2009 to March 2010: the investigation in Italy. Euro Surveill 2013; 18:20424. [DOI: 10.2807/ese.18.11.20424-en] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
After an urgent inquiry into a suspected international outbreak of Salmonella Goldcoast infection was launched by Hungary in October 2009 a nation-wide multidisciplinary investigation was carried out in Italy. The aims were to verify whether the higher than expected number of cases of S. Goldcoast infection that had occurred in Italy in the previous months were linked to the outbreak in Hungary and to determine their origin. Between June 2009 and March 2010, 79 confirmed cases of S. Goldcoast infection were identified. Of these, 17 were part of three different point-source outbreaks probably associated with the consumption of salami. Eating salami was also reported by 20 of the 39 sporadic cases that could be interviewed. Fifteen strains of S. Goldcoast isolated from the cases were typed by pulsed-field gel electrophoresis. They shared more than 90% homology with the Hungarian epidemic strain and were also highly similar to S. Goldcoast strains that had been isolated in Italy from pigs and pork-containing food items in 2009 and 2010. Although the origin of the outbreak and the common source linking the Hungarian and the Italian cases could not be definitively identified, our results suggest a possible zoonotic connection of the outbreak cases with the pork production chain.
Collapse
Affiliation(s)
- G Scavia
- Istituto Superiore di Sanitá, Rome, Italy
| | | | - I Luzzi
- Istituto Superiore di Sanitá, Rome, Italy
| | - A Lenglet
- European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
| | - A Ricci
- Istituto Zooprofilattico Sperimentale delle Venezie, Padua, Italy
| | - L Barco
- Istituto Zooprofilattico Sperimentale delle Venezie, Padua, Italy
| | - A Pavan
- Regione Lombardia, Milan, Italy
| | - F Zaffanella
- Azienda Sanitaria Locale della provincia di Mantova, Mantova, Italy
| | | |
Collapse
|
34
|
|
35
|
Casari S, Suligoi B, Camoni L, Pavan A, Macchi L, Capelli M, Paraninfo G, Compostella S, Castelli F, Carosi G, Donato F. Epidemiological and clinical characteristics and behaviours of individuals with newly diagnosed HIV infection: a multicentre study in north Italy. J Prev Med Hyg 2012; 53:190-194. [PMID: 23469586] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
INTRODUCTION We aimed to investigate socio-demographic, clinical and epidemiological characteristics and behaviours of subjects with new HIV diagnosis. METHODS We carried out a multi-centre cross-sectional study comprising 17 infectious diseases units in the Lombardy Region, North Italy. All subjects with a first positive test for HIV infection examined in 2008-09 were interviewed using a structured questionnaire. RESULTS 472 patients were enrolled (mean age 39.8 years, standard deviation [SD] 11.5), mostly males (78%), and born in Italy (77%). The most common routes of HIV transmission were heterosexual intercourse (49%) and sex among men who have sex with men (MSM) (40%). Never/sometimes use of a condom with occasional partners was associated with male gender, heterosexual transmission route, and with >10 sexual partners in their lifetime. 47% had previous HIV negative tests. Having had more than 2 previous HIV negative tests was associated with younger age, MSM transmission route, CD4+ lymphocyte count >350/microl and self-perception of risk. DISCUSSION This study shows that there is a large portion of the adult population, especially heterosexual men aged 45 years and over, who are at high risk of acquiring and transmitting HIV infection and undergoing the HIV diagnostic test late, due to risk behaviours combined with a low perception of being at risk. Compared to people infected by heterosexual contacts, MSM show a greater awareness of being at risk of infection, but this knowledge has a low impact in reducing at-risk behaviours.
Collapse
Affiliation(s)
- S Casari
- Department of Infectious Diseases, Spedali Civili General Hospital, Brescia, Italy.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
|
37
|
Mughini-Gras L, Graziani C, Biorci F, Pavan A, Magliola R, Ricci A, Gilli G, Carraro E, Busani L. Surveillance of acute infectious gastroenteritis (1992–2009) and food-borne disease outbreaks (1996–2009) in Italy, with a focus on the Piedmont and Lombardy regions. Euro Surveill 2012. [DOI: 10.2807/ese.17.08.20098-en] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
We describe trends in the occurrence of acute infectious gastroenteritis (1992 to 2009) and food-borne disease outbreaks (1996 to 2009) in Italy. In 2002, the Piedmont region implemented a surveillance system for early detection and control of food-borne disease outbreaks; in 2004, the Lombardy region implemented a system for surveillance of all notifiable human infectious diseases. Both systems are internet based. We compared the regional figures with the national mean using official notification data provided by the National Infectious Diseases Notification System (SIMI) and the National Institute of Statistics (ISTAT), in order to provide additional information about the epidemiology of these diseases in Italy. When compared with the national mean, data from the two regional systems showed a significant increase in notification rates of non-typhoid salmonellosis and infectious diarrhoea other than non-typhoid salmonellosis, but for food-borne disease outbreaks, the increase was not statistically significant. Although the two regional systems have different objectives and structures, they showed improved sensitivity regarding notification of cases of acute infectious gastroenteritis and, to a lesser extent, food-borne disease outbreaks, and thus provide a more complete picture of the epidemiology of these diseases in Italy.
Collapse
Affiliation(s)
- L Mughini-Gras
- Istituto Superiore di Sanità, Department of Veterinary Public Health and Food Safety, Rome, Italy
| | - C Graziani
- Istituto Superiore di Sanità, Department of Veterinary Public Health and Food Safety, Rome, Italy
| | - F Biorci
- University of Turin, Department of Public Health and Microbiology, Turin, Italy
| | - A Pavan
- General Public Health Directorate, Unit of Prevention and control of Infectious Diseases, Food Safety and Nutrition, Lombardy region, Milan, Italy
| | - R Magliola
- Regional reference centre for surveillance, prevention and control of food-borne diseases, Piedmont region, Turin, Italy
| | - A Ricci
- Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Padua, Italy
| | - G Gilli
- University of Turin, Department of Public Health and Microbiology, Turin, Italy
| | - E Carraro
- University of Piemonte Orientale ‘Amedeo Avogadro’, Department of Life Sciences, Alessandria, Italy
| | - L Busani
- Istituto Superiore di Sanità, Department of Veterinary Public Health and Food Safety, Rome, Italy
| |
Collapse
|
38
|
Mughini-Gras L, Graziani C, Biorci F, Pavan A, Magliola R, Ricci A, Gilli G, Carraro E, Busani L. Surveillance of acute infectious gastroenteritis (1992-2009) and food-borne disease outbreaks (1996-2009) in Italy, with a focus on the Piedmont and Lombardy regions. Euro Surveill 2012; 17:20098. [PMID: 22401508] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/31/2023] Open
Abstract
We describe trends in the occurrence of acute infectious gastroenteritis (1992 to 2009) and food-borne disease outbreaks (1996 to 2009) in Italy. In 2002, the Piedmont region implemented a surveillance system for early detection and control of food-borne disease outbreaks; in 2004, the Lombardy region implemented a system for surveillance of all notifiable human infectious diseases. Both systems are internet based. We compared the regional figures with the national mean using official notification data provided by the National Infectious Diseases Notification System (SIMI) and the National Institute of Statistics (ISTAT), in order to provide additional information about the epidemiology of these diseases in Italy. When compared with the national mean, data from the two regional systems showed a significant increase in notification rates of non-typhoid salmonellosis and infectious diarrhea other than non-typhoid salmonellosis, but for foodborne disease outbreaks, the increase was not statistically significant. Although the two regional systems have different objectives and structures, they showed improved sensitivity regarding notification of cases of acute infectious gastroenteritis and, to a lesser extent, food-borne disease outbreaks, and thus provide a more complete picture of the epidemiology of these diseases in Italy.
Collapse
Affiliation(s)
- L Mughini-Gras
- Istituto Superiore di Sanita, Department of Veterinary Public Health and Food Safety, Rome, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Andreetti C, Ibrahim M, Ciccone A, D'Andrilli A, Poggi C, Maurizi G, Pavan A, Rendina EA. Autologus platelet gel for the management of persistent alveolar fistula after lung resection. MINERVA CHIR 2010; 65:695-699. [PMID: 21224802] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Postoperative alveolar fistula (AF) associated with pleural cavity (PC) is a serious complication and a therapeutic challenge in thoracic surgery. The purpose of this study was to assess the efficacy of the use of the autologous platelet gel for the treatment of AF and PC. We treated a patient with post lung resection persistent alveolar fistula using a autologous platelet gel, a cellular compose produces at the Division of Immunohaematoligy and Trasfusion. The platelet gel-PRP (Platelet-Rich Plasma) is a biological material made of autologous platelets, extracted from a small amount of the patient's blood, centrifuged at 1100 g for 9 min. The PRP obtained was activated by addition of autologous thrombin and calcium chloride to form a matrix of fibrin (PRFM) thick. The patient presented important air leak after middle lobe wedge resection for solitary lung lesion with standard open decortication for important pleural adhesions post pleuritis. On postoperative day XIII the patient developed a thoracic empyema and consequently underwent a antibiotic pleural irrigation through the chest drainage based on the microbiological analysis of the pleural fluid. After a week we obtained the resolution of the empyema but a residual space remained and air leak persisted. We treated the patient with autologous platelet gel. We administer 7.5 mL of the autologous platelet gel across the chest drainage ever 72 hours for 3 times. After the third application we had the closure of the cavity and the cessation of air leak. Autologous platelet gel is easy to use, safe and inexpensive. It can be considered a valid therapeutic option in selected patients with a alveolar fistula and a lung partial re-expansion. The product consist of a significant amount of cellular components with healing anti-inflammatory an proregenerative properities that permit the body to heal tissue wounds faster and more efficiently. A sterile pleural cavity is fundamental conditions for the final success of the procedure.
Collapse
Affiliation(s)
- C Andreetti
- Department of Thoracic Surgery, La Sapienza, University of Rome, Sant'Andrea Hospital, Rome, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
40
|
Oggioni C, Fontana G, Pavan A, Gramegna M, Ferretti V, Piatti A, Edefonti V, Tunnesi S, Sala G, Pontello M. [Investigation of potential risk factors for Salmonella enterica subsp enterica serotype Napoli: a nested case-control study in Lombardia region]. Ann Ig 2010; 22:327-335. [PMID: 21425643] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Enter-net surveillance system has detected the re-emergence of Salmonella enterica subsp enterica serotype Napoli (S. Napoli) since 2002. Preliminary data show that food vehicle could not be the only one implicated in the transmission of this serotype. A nested case-control study has been conducted using data form a prospective cohort: for each salmonellosis notification in Lombardia from May 2004 to December 2005 an ad hoc epidemiological investigation has been performed. Cases have been defined as subjects affected by salmonellosis with a positive faecal sample for Salmonella serotype Napoli and controls as subjects affected by salmonellosis with a positive faecal sample for Salmonella serotype not Napoli. Among 2185 salmonellosis notifications collected by 12 of 15 Local Health Authorities, we identified 67 cases and 867 controls. Infection due to S. Napoli were significantly more common among subjects with exposure to surface water (adjusted Odds Ratio (OR) = 3,82; 95% Confidence Interval (C.I.)=1,03-14,19), to domestic animals (adjusted OR = 3,22; 95% C.I. = 1,28-8,10) and among person who practice activities connected to surface water (adjusted OR 3,88; 95% C.I.=1,15-13,05) compared to subjects not exposed to these factors. Hyperendemia of S. Napoli could be attributable to an animal reservoir not yet identified: surface water contamination may be a direct (waterborne infection) or indirect (foodborne infection) vehicle for transmission of S. Napoli. behaviour. Regarding the relations of the neuroendocrine parameters and driving behaviour, positive correlations were observed between dopamine levels and frequency of driving violations while a negative relationship was found between adrenaline levels and frequency of driving errors. In conclusion the identification of psycho-physiological variables related to driving risky behaviour might be a useful instrument to design traffic safety programs tailored to high risk subjects.
Collapse
Affiliation(s)
- C Oggioni
- Dipartimento di Sanità Pubblica-Microbiologia-Virologia, Università degli Studi di Milano
| | | | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Campana G, Casco C, Pavan A, Manassi M. Rapid forms of visual motion priming and motion aftereffect have similar time course but different neural substrates in first- and second-order motion. J Vis 2010. [DOI: 10.1167/9.8.685] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
42
|
Rizzo C, Vescio F, Declich S, Finarelli AC, Macini P, Mattivi A, Rossini G, Piovesan C, Barzon L, Palù G, Gobbi F, Macchi L, Pavan A, Magurano F, Ciufolini MG, Nicoletti L, Salmaso S, Rezza G. West Nile virus transmission with human cases in Italy, August - September 2009. Euro Surveill 2009. [DOI: 10.2807/ese.14.40.19353-en] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
In 2009, to date 16 human cases of West Nile neuroinvasive disease (WNND) have been reported in Italy, in three regions: Veneto, Emilia-Romagna and Lombardia. The number of cases is higher compared with last year when nine cases were identified (eight cases of WNND and one case of West Nile fever) and the geographical distribution indicates spread from east to west.
Collapse
Affiliation(s)
- C Rizzo
- National Centre for Epidemiology, Surveillance and Health Promotion, National Institute of Health (Istituto Superiore di Sanità, ISS), Rome, Italy
| | - F Vescio
- Department of Infectious, Parasitic and Immune-mediated Diseases, National Institute of Health (Istituto Superiore di Sanità, ISS), Rome, Italy
| | - S Declich
- National Centre for Epidemiology, Surveillance and Health Promotion, National Institute of Health (Istituto Superiore di Sanità, ISS), Rome, Italy
| | - A C Finarelli
- Public Health Service, Emilia-Romagna Region, Bologna, Italy
| | - P Macini
- Public Health Service, Emilia-Romagna Region, Bologna, Italy
| | - A Mattivi
- Public Health Service, Emilia-Romagna Region, Bologna, Italy
| | - G Rossini
- Regional Reference Centre for Microbiological Emergencies (CRREM), Microbiology Unit, Azienda Ospedaliero-Universitaria di Bologna, Policlinico S.Orsola-Malpighi, Bologna, Italy
| | - C Piovesan
- Direction of Prevention, Veneto region, Venice, Italy
| | - L Barzon
- Regional Reference Centre for Infectious Diseases, Microbiology and Virology Unit, Azienda Ospedaliera di Padova, Padua, Italy
| | - G Palù
- Regional Reference Centre for Infectious Diseases, Microbiology and Virology Unit, Azienda Ospedaliera di Padova, Padua, Italy
| | - F Gobbi
- Department of Prevention, ULSS 20, Verona, Italy
- Centre for Tropical Diseases, Sacro Cuore Hospital, Negrar (Verona), Italy
| | - L Macchi
- Regional Health Authority of Lombardy, Milan, Italy
| | - A Pavan
- Regional Health Authority of Lombardy, Milan, Italy
| | - F Magurano
- Department of Infectious, Parasitic and Immune-mediated Diseases, National Institute of Health (Istituto Superiore di Sanità, ISS), Rome, Italy
| | - M G Ciufolini
- Department of Infectious, Parasitic and Immune-mediated Diseases, National Institute of Health (Istituto Superiore di Sanità, ISS), Rome, Italy
| | - L Nicoletti
- Department of Infectious, Parasitic and Immune-mediated Diseases, National Institute of Health (Istituto Superiore di Sanità, ISS), Rome, Italy
| | - S Salmaso
- National Centre for Epidemiology, Surveillance and Health Promotion, National Institute of Health (Istituto Superiore di Sanità, ISS), Rome, Italy
| | - G Rezza
- Department of Infectious, Parasitic and Immune-mediated Diseases, National Institute of Health (Istituto Superiore di Sanità, ISS), Rome, Italy
| |
Collapse
|
43
|
Rizzo C, Vescio F, Declich S, Finarelli AC, Macini P, Mattivi A, Rossini G, Piovesan C, Barzon L, Palù G, Gobbi F, Macchi L, Pavan A, Magurano F, Ciufolini MG, Nicoletti L, Salmaso S, Rezza G. West Nile virus transmission with human cases in Italy, August - September 2009. Euro Surveill 2009; 14:19353. [PMID: 19822123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023] Open
Abstract
In 2009, to date 16 human cases of West Nile neuroinvasive disease (WNND) have been reported in Italy, in three regions: Veneto, Emilia-Romagna and Lombardia. The number of cases is higher compared with last year when nine cases were identified (eight cases of WNND and one case of West Nile fever) and the geographical distribution indicates spread from east to west.
Collapse
Affiliation(s)
- C Rizzo
- National Centre for Epidemiology, Surveillance and Health Promotion, National Institute of Health (Istituto Superiore di Sanita, ISS), Rome, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Pavan A, Campana G, Guerreschi M, Manassi M, Casco C. Separate motion-detecting mechanisms for first- and second-order patterns revealed by rapid forms of visual motion priming and motion aftereffect. J Vis 2009; 9:27.1-16. [PMID: 20053090 DOI: 10.1167/9.11.27] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2009] [Accepted: 10/02/2009] [Indexed: 11/24/2022] Open
|
45
|
Scarcella C, Carasi S, Cadoria F, Macchi L, Pavan A, Salamana M, Alborali GL, Losio MN, Boni P, Lavazza A, Seyler T. An outbreak of viral gastroenteritis linked to municipal water supply, Lombardy, Italy, June 2009. Euro Surveill 2009; 14. [DOI: 10.2807/ese.14.29.19274-en] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
We report an outbreak of viral gastroenteritis linked to municipal drinking water in a town in northern Italy in June 2009. Over one month we identified 299 probable cases of whom 30 were confirmed for at least one of the following viruses: norovirus, rotavirus, enterovirus or astrovirus. Water samples and filters from the water system also tested positive for norovirus and enterovirus. Control measures included treating the water system with chlorine dioxide and filters with peracetic acid, while providing temporary alternative sources of drinking water to the population.
Collapse
Affiliation(s)
- C Scarcella
- Azienda Sanitaria Locale della Provincia di Brescia (Local Health Authority of Brescia), Brescia, Italy
| | - S Carasi
- Azienda Sanitaria Locale della Provincia di Brescia (Local Health Authority of Brescia), Brescia, Italy
| | - F Cadoria
- Azienda Sanitaria Locale della Provincia di Brescia (Local Health Authority of Brescia), Brescia, Italy
| | - L Macchi
- Direzione Generale Sanità Lombardia (Regional Health Authority of Lombardy), Milan, Italy
| | - A Pavan
- Direzione Generale Sanità Lombardia (Regional Health Authority of Lombardy), Milan, Italy
| | - M Salamana
- Direzione Generale Sanità Lombardia (Regional Health Authority of Lombardy), Milan, Italy
| | - G L Alborali
- Istituto Zooprofilattico Sperimentale Lombardia ed Emilia-Romagna (IZSLER, Lombardy and Emilia Romagna Experimental Zooprophylactic Institute), Brescia, Italy
| | - M N Losio
- Istituto Zooprofilattico Sperimentale Lombardia ed Emilia-Romagna (IZSLER, Lombardy and Emilia Romagna Experimental Zooprophylactic Institute), Brescia, Italy
| | - P Boni
- Istituto Zooprofilattico Sperimentale Lombardia ed Emilia-Romagna (IZSLER, Lombardy and Emilia Romagna Experimental Zooprophylactic Institute), Brescia, Italy
| | - A Lavazza
- Istituto Zooprofilattico Sperimentale Lombardia ed Emilia-Romagna (IZSLER, Lombardy and Emilia Romagna Experimental Zooprophylactic Institute), Brescia, Italy
| | - T Seyler
- Centro nazionale di epidemiologia, sorveglianza e promozione della salute (National Centre for Epidemiology, Surveillance and Health Promotion), Istituto Superiore di Sanità (ISS, National Institute of Health), Rome, Italy
| |
Collapse
|
46
|
Pulcinelli FM, Manzari G, Bartoli M, Faggioni A, Mancusa RL, Pavan A, Sansolini T, Torrisi MR, Gazzaniga PP. Mechanisms of the Platelet Proaggregating Activity of Human Carcinoma A431 Cells. Platelets 2009; 6:213-20. [DOI: 10.3109/09537109509078458] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
47
|
Andreoni B, Crosta C, Sonzogni A, Pirola M, Pavan A, Bisanti L, Senore C, Sassatelli R, Sguinzi R, Bertani E, Bianchi P, Chiappa A. Comparison between endoscopic and surgical treatment of screen-detected versus non-screen-detected colorectal cancers. Ecancermedicalscience 2009; 3:142. [PMID: 22276007 PMCID: PMC3224002 DOI: 10.3332/ecancer.2009.142] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2009] [Indexed: 11/08/2022] Open
Affiliation(s)
- B Andreoni
- Division of General-Laparoscopic Surgery, European Institute of Oncology, Milan 20141, Italy
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Macchi L, Pavan A, Carreri V. [Law simplification: the Lombardy Region experience]. Ann Ig 2008; 20:25-30. [PMID: 18773601] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
Lombardy Region, adopted its own rules to reorganize and to relaunch health prevention activities. Particularly, the started way foresees for the useless activity divestment, not backed by scientific evidences and of no effect to preserve public health. In this optics, the run is inserted that foresees the planning of the activity of official control, based on the acquisition of the epidemiological and the productive, economic and social territorial context data, so to be able to point out interventions priorities and to graduate health risks. Similarly the integration among different operators, belonging to different Services and Departments too, it's considered necessary, passing from the planning of independent Plans of sector to Plans bringing common and joined objectives, in a business logic. The change of perspective, needs a suitable monitoring of the obtained results aiming to start deepened evaluations to implement or to reassess the regional strategic lines.
Collapse
Affiliation(s)
- L Macchi
- Direzione Generale Sanità, Regione Lombardia, Milano.
| | | | | |
Collapse
|
49
|
Cipriani P, Guiducci S, Miniati I, Cinelli M, Urbani S, Marrelli A, Dolo V, Pavan A, Saccardi R, Tyndall A, Giacomelli R, Cerinic MM. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis. ACTA ACUST UNITED AC 2007; 56:1994-2004. [PMID: 17530639 DOI: 10.1002/art.22698] [Citation(s) in RCA: 105] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
OBJECTIVE Systemic sclerosis (SSc) is a disorder characterized by vascular damage and fibrosis of the skin and internal organs. Despite marked tissue hypoxia, there is no evidence of compensatory angiogenesis. The ability of mesenchymal stem cells (MSCs) to differentiate into endothelial cells was recently demonstrated. The aim of this study was to determine whether impaired differentiation of MSCs into endothelial cells in SSc might contribute to disease pathogenesis by decreasing endothelial repair. METHODS MSCs obtained from 7 SSc patients and 15 healthy controls were characterized. The number of colony-forming unit-fibroblastoid colonies was determined. After culture in endothelial-specific medium, the endothelial-like MSC (EL-MSC) phenotype was assessed according to the surface expression of vascular endothelial growth factor receptors (VEGFRs). Senescence, chemoinvasion, and capillary morphogenesis studies were also performed. RESULTS MSCs from SSc patients displayed the same phenotype and clonogenic activity as those from controls. In SSc MSCs, a decreased percentage of VEGFR-2+, CXCR4+, VEGFR-2+/CXCR4+ cells and early senescence was detected. After culturing, SSc EL-MSCs showed increased expression of VEGFR-1, VEGFR-2, and CXCR4, did not express CD31 or annexin V, and showed significantly decreased migration after specific stimuli. Moreover, the addition of VEGF and stromal cell-derived factor 1 to cultured SSc EL-MSCs increased their angiogenic potential less than that in controls. CONCLUSION Our data strongly suggest that endothelial repair may be affected in SSc. The possibility that endothelial progenitor cells could be used to increase vessel growth in chronic ischemic tissues may open up new avenues in the treatment of vascular damage caused by SSc.
Collapse
MESH Headings
- Adolescent
- Adult
- Case-Control Studies
- Cell Differentiation/physiology
- Cells, Cultured
- Cellular Senescence
- Chemokine CXCL12
- Chemokines, CXC/metabolism
- Endothelial Cells/physiology
- Endothelium, Vascular/metabolism
- Endothelium, Vascular/pathology
- Endothelium, Vascular/physiopathology
- Female
- Humans
- Immunophenotyping
- Male
- Mesenchymal Stem Cells/metabolism
- Mesenchymal Stem Cells/pathology
- Mesenchymal Stem Cells/physiology
- Middle Aged
- Neovascularization, Pathologic
- Phenotype
- Platelet Endothelial Cell Adhesion Molecule-1/metabolism
- Receptors, CXCR4/metabolism
- Receptors, Vascular Endothelial Growth Factor/metabolism
- Scleroderma, Systemic/pathology
- Scleroderma, Systemic/physiopathology
- Stem Cells/metabolism
- Stem Cells/pathology
Collapse
|
50
|
Pavan A, Wang F. Robustness of PSPACE-complete sets. INFORM PROCESS LETT 2007. [DOI: 10.1016/j.ipl.2007.02.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|